Indian pharma cos need to join forces to counter IP threats
A key takeaway from the 6th Annual Pharma IPR Indian 2017 was the need for concerted action among Indian pharma peers on domestic…
Author
TA Associates invests in Ideal Cures
Ideal Cures aims to leverage TA’s networking and other corporate development capabilities to accelerate growth
Pharma industry appreciates MoHF&W’s move on National Health Policy
"National Health Policy is a forward looking policy which would revive India's healthcare system by ensuring that Indians have…
Govt gets Rs 672 Crs fine from pharma cos for overcharging
Since inception, the NPPA has issued 1,527 demand notices to companies for overcharging
Eli Lilly India launches Humalog 200U/mL KwikPen
The pen offers physicians an alternative that allows patients to inject 50 per cent less insulin volume
DSM Sinochem Pharmaceuticals in agreement with Sandoz
The agreement will licence certain DSP intellectual property assets for the manufacture of beta lactam antibiotics
JP Nadda addresses WHO Regional Health Ministers’ Meeting on TB
Highlights the achievements of India in containing TB
Skill development project for life sciences sector launched in Maharashtra
Low occupation standards set to threaten India’s potential pharma exports
Agilent Technologies receives 2017 Scientists’ Choice Award for best new separation product
The award recognises the product that has made the most difference to chromatography